Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
genentech
4
×
life sciences
national
4
×
national blog main
novartis
4
×
biogen
fda
gene therapy
national top stories
new york top stories
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
clinical trials
detroit blog main
detroit top stories
drug prices
eli lilly
indiana blog main
indiana top stories
ipo
johnson & johnson
new york blog main
pfizer
president trump
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
spinal muscular atrophy
texas blog main
texas top stories
What
fda
bio
drug
gene
new
roundup
therapy
alzheimer’s
approved
atrophy
august
biotech
busy
chemistry
cmc
companies
consistent
controls
daily
days
decisions
devices
different
drugs
ensure
evrysdi
fail
friday
green
home
increases
intended
lack
latest
legacy
lights
liquid
manufacturing
medicine
muscular
Language
unset
Current search:
genentech
×
novartis
×
national
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More